Blood Marker Soluble PD-1 Flags Cancer Return After Liver Transplant in Immunotherapy Patients
A pretransplant blood test for soluble PD-1 identified liver cancer patients at high risk of tumor recurrence after immunotherapy and ...
A pretransplant blood test for soluble PD-1 identified liver cancer patients at high risk of tumor recurrence after immunotherapy and ...
An exploratory analysis of TCGA data suggests that isolated TERT promoter mutation, without BRAF V600E, may mark the worst-prognosis subgroup ...
A multiomics study identifies the deubiquitinase OTUD7B as a central driver of epithelial remodelling, mitochondrial reprogramming, and immune suppression in ...
A dual-trajectory study of 462 sepsis patients finds that a rising CRP-albumin pattern in the first two ICU weeks nearly ...
A new study profiles all 23 human MMP genes in oral squamous cell carcinoma and validates MMP-1, MMP-10, and MMP-9 ...
Colorectal cancer remains one of the world's most formidable health challenges, ranking as the second leading cause of cancer-related mortality ...
A retrospective cohort study from Indonesia's national referral hospital links vimentin expression to dramatically shorter survival in triple-negative breast cancer ...
A new study shows that combining brain oxygen saturation, EEG-derived sedation monitoring, clinical scores and a blood biomarker can predict ...
A new study finds that the microscopic distance between a T3 colon tumor and the serosal surface is linked to ...
A retrospective cohort study using the MIMIC-IV database found that elevated blood urea nitrogen within 24 hours of ICU admission ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine